Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13741-13755
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13741
Table 6 Clinical trial of ramucirumab
PatientPhaseTreatmentnOS (mo)PFS (mo)RRDCR
Second-line treatment for advanced gastric cancer or GEJ adenocarcinoma (REGARD)IIIBSC1173.81.32.6%23.1%
Ramucirumab2385.22.13.4%48.7%